IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
baca selengkapnya
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
1168 hari yang lalu
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1434 hari yang lalu
U.S. Dollar Ticks Lower As Investors Monitor Developments In Middle East
The U.S. Dollar value posted incremental losses on Friday as markets focused on the U.S. call to Iran for discussions to avert a planned intense attack by the U.S. on Iran after November mid-term elections. Iran has not responded until now.
RTTNews
|
1 hari yang lalu
TSX Drops Nearly 2.5%; Materials, Tech Stocks Down Sharply
Canadian stocks are down sharply on Friday amid renewed fears about inflation and interest rates following oil prices climbing higher amid supply concerns after a tanker attack in the Strait of Hormuz.
RTTNews
|
1 hari yang lalu
Swiss Market Ends Modestly Higher
The Switzerland market's benchmark SMI ended modestly higher on Friday after holding firm throughout the trading session, outperforming most of its peers in Europe.
RTTNews
|
1 hari yang lalu
Major European Markets End Mixed As Investors React To Earnings, Economic Data
The major European markets closed mixed on Friday even as most of the other markets across the continent ended notably lower, as investors reacted to a slew of corporate earnings announcements and the latest batch of regional economic data.
Higher oil prices and weakness in the tech sector due to renewed uncertainty about returns on AI-related investments hurt sentiment.
RTTNews
|
1 hari yang lalu
Chicago Business Barometer Pulls Back But Still Indicates Growth In October
Growth in Chicago-area business activity slowed moderately in the month of October, according to a report released by MNI Indicators on Friday. The report said the Chicago business barometer fell to 55.3 in October after spiking to 58.8 in September, although a reading above 50 still indicates growth. Economists had expected the business barometer to pull back to 56.0.
RTTNews
|
1 hari yang lalu
Colgate-Palmolive Q3 Results Rise, Lifts FY26 Base Business EPS View; Stock Gains
Consumer products major Colgate-Palmolive Co., while reporting higher third-quarter results, on Friday confirmed fiscal 2026 outlook for earnings per share. Further, the firm raised guidance for Base Business earnings per share and gross profit margin, while narrowing sales growth view. In pre-market activity on the NYSE, the shares were gaining around 3.34 percent
RTTNews
|
1 hari yang lalu
